Background: The HIV reservoir in peripheral blood mononuclear cells (PBMC) contributes to HIV-associated dementia (HAD) pathogenesis. However it is unclear whether it contributes to non-demented HIV-associated neurocognitive disorders (HAND) that are more common in chronic HIV infection (CHI), especially in HIV+ persons on long-term combined antiretroviral therapy (cART).
Methods: Eighty adults (mean age=55, 1 female) with CHI on cART (>97% with undetectable plasma and CSF HIV RNA) underwent assessments of neurocognition and pre-morbid cognitive ability (Australian standardized index of education and reading) at two visits 18 months apart. HIV DNA in PBMC was measured by real-time PCR at the same time-points. Historical HIV disease data included: duration of HIV infection (median=19 years); ART during 1st year of HIV infection (20%); current (556) and nadir (194) median CD4 count; none developed AIDS during study.
Results: At baseline, 46% of the patients had non-demented HAND; 7.5% had HAD. At follow-up, neurocognitive function declined in 14%, and this was more likely in those with baseline HAD (p<.03). Low pre-morbid cognitive ability was uniquely associated with HAD (p<.05). Log(n) HIV DNA copies were stable between study visits (5.2 vs. 5.1 per 106 PBMC; r=.73). Univariate analyses showed that baseline HIV DNA was higher in those with longer duration of infection (r=.28; p<.02, Fig.1B) as well as those with lower pre-morbid cognitive ability (r=-.24; p<.04, Fig.1A) and was higher in those with no treatment during HIV infection 1st year (5.4 vs. 4.5; p=.03, Fig.1C). Multiple regression models showed that baseline HIV DNA was not associated with baseline overall neurocognitive performance in unadjusted and adjusted (above significant factors plus CD4 count, age, cART duration) models. Change in HIV DNA between study time-points was associated with a decline in motor-coordination, r=-26, p<.03 (Fig.1D); and semantic fluency, r=-25, p<.03; and this remained significant in adjusted models (p<.02).
Conclusions: PBMC HIV DNA was not associated with current non-demented HAND, but an increase in HIV DNA during the study period was associated with decline in some neurocognitive functions. Further, the role of PBMC HIV DNA in HAD pathogenesis is moderated by pre-morbid cognitive. Lastly, higher baseline HIV DNA was associated with longer duration of HIV disease. Further study is needed to investigate if these results are reproduced when focusing on HIV DNA in monocytes.